Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
A Phase 1, randomized, double-blind, placebo-controlled, crossover study to assess the effect
of ITCA 650 on the pharmacokinetics (PK) of once daily administration of Levora® (ethinyl
estradiol 0.3 mg (EE) and levonorgestrel 0.15 mg (LNG) in healthy premenopausal female
subjects.